Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Serotonin reduction in post-acute sequelae of viral infection
Andrea C. Wong, Ashwarya S. Devason, Iboro C. Umana, et al.
Cell (2023) Vol. 186, Iss. 22, pp. 4851-4867.e20
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Long COVID science, research and policy
Ziyad Al‐Aly, Hannah Davis, Lisa McCorkell, et al.
Nature Medicine (2024) Vol. 30, Iss. 8, pp. 2148-2164
Open Access | Times Cited: 109
Long COVID: a clinical update
Trisha Greenhalgh, Manoj Sivan, Alice Perlowski, et al.
The Lancet (2024) Vol. 404, Iss. 10453, pp. 707-724
Closed Access | Times Cited: 85
Solving the puzzle of Long Covid
Ziyad Al‐Aly, Eric J. Topol
Science (2024) Vol. 383, Iss. 6685, pp. 830-832
Closed Access | Times Cited: 65
The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China
Wenting Zuo, Di He, Chaoyang Liang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 8, pp. 845-855
Open Access | Times Cited: 62
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 33
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review
Jingyan Yang, Kristen Markus, Kathleen M. Andersen, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e077886-e077886
Open Access | Times Cited: 23
Long Covid and Impaired Cognition — More Evidence and More Work to Do
Ziyad Al‐Aly, Clifford J. Rosen
New England Journal of Medicine (2024) Vol. 390, Iss. 9, pp. 858-860
Open Access | Times Cited: 20
Navigating neurologic post-COVID-19 conditions in adults: Management strategies for cognitive dysfunction, headaches and neuropathies
A Chopra, Nicholas Franko, Eric J. Chow
Life Sciences (2025) Vol. 362, pp. 123374-123374
Closed Access | Times Cited: 2
The neurobiology of SARS-CoV-2 infection
Jenny Meinhardt, Simon Streit, Carsten Dittmayer, et al.
Nature reviews. Neuroscience (2023) Vol. 25, Iss. 1, pp. 30-42
Closed Access | Times Cited: 35
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial
Roger S. McIntyre, Lee Phan, Angela T.H. Kwan, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 849-857
Closed Access | Times Cited: 30
Assessing the effect of selective serotonin reuptake inhibitors in the prevention of post-acute sequelae of COVID-19
Hythem Sidky, Kristen Hansen, Andrew T. Girvin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 24, pp. 115-125
Open Access | Times Cited: 15
Transfer of IgG from Long COVID patients induces symptomology in mice
Hung‐Jen Chen, Brent Appelman, Hanneke L.D.M. Willemen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 15
Unravelling shared mechanisms: insights from recent ME/CFS research to illuminate long COVID pathologies
Sarah J. Annesley, Daniel Missailidis, Benjamin Heng, et al.
Trends in Molecular Medicine (2024) Vol. 30, Iss. 5, pp. 443-458
Open Access | Times Cited: 14
Systems analysis of innate and adaptive immunity in Long COVID
Michael J. Peluso, Mohamed Abdel‐Mohsen, Timothy J. Henrich, et al.
Seminars in Immunology (2024) Vol. 72, pp. 101873-101873
Closed Access | Times Cited: 14
Virology—The next fifty years
Edward C. Holmes, Florian Krammer, Felicia Goodrum
Cell (2024) Vol. 187, Iss. 19, pp. 5128-5145
Open Access | Times Cited: 12
Long COVID: Long-Term Impact of SARS-CoV2
Huda Makhluf, Henry Madany, Kenneth Kim
Diagnostics (2024) Vol. 14, Iss. 7, pp. 711-711
Open Access | Times Cited: 11
Exploring the Complexities of Long COVID
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 11
Looking at the Data on Smoking and Post-COVID-19 Syndrome—A Literature Review
Antigona Trofor, Daniela Robu Popa, Oana Melinte, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 97-97
Open Access | Times Cited: 9
Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial
Dhammika Leshan Wannigama, Cameron Hurst, Phatthranit Phattharapornjaroen, et al.
EClinicalMedicine (2024) Vol. 70, pp. 102517-102517
Open Access | Times Cited: 9
The Role of Coinhibitory Receptors in B Cell Dysregulation in SARS-CoV-2–Infected Individuals with Severe Disease
Suguru Saito, Najmeh Bozorgmehr, Wendy Sligl, et al.
The Journal of Immunology (2024) Vol. 212, Iss. 10, pp. 1540-1552
Open Access | Times Cited: 9
How to understand the overlap of long COVID, chronic fatigue syndrome/myalgic encephalomyelitis, fibromyalgia and irritable bowel syndromes
Don L. Goldenberg
Seminars in Arthritis and Rheumatism (2024) Vol. 67, pp. 152455-152455
Closed Access | Times Cited: 9
Host–microbe serotonin metabolism
Emilia Nunzi, Marilena Pariano, Claudio Costantini, et al.
Trends in Endocrinology and Metabolism (2024)
Open Access | Times Cited: 8
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 1
Neurobiology of COVID‐19‐Associated Psychosis/Schizophrenia: Implication of Epidermal Growth Factor Receptor Signaling
Hiroyuki Nawa, Masaaki Murakami
Neuropsychopharmacology Reports (2025) Vol. 45, Iss. 1
Open Access | Times Cited: 1
Prevalence and risk factors for long COVID in China: a systematic review and meta-analysis of observational studies
Le-Yan Hu, A. Cai, Bo Li, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102652-102652
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top